Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing biologics therapeutics today.
Register below to receive a live stream of the discussion as well a complimentary report outlining the key findings and conclusions covered.
09 November 2021 | 14:00 GMT (UTC+0)
The inhalation industry has recently benefitted from renewed interest in the inhaled administration of biologics. The potential for better respiratory and systemic delivery, as well as increased patient comfort, make the inhaled route an attractive proposition to deliver therapies. Our November discussion group brings together an exclusive panel of key opinion leaders discussing the key factors behind the market’s growth, research priorities, future outlook & how to overcome challenges in this exciting area.
Part 1: Presentation: History of Inhaled Biologics
Speaker: David Cipolla, Vice President of Research, Insmed
Part 2: Discussion: Advancing the Development & Delivery of Inhaled Biologics
Carsten Erdhart, Professor in Pharmaceutics and Biopharmaceutics, Trinity College Dublin
Francesca Buttini, Associate Professor, University of Parma
Pavan Muttil, Associate Professor, University of New Mexico
Taking place November 2021
Viewer Registration Coming Soon
Reports and write-ups pertaining to previous Discussion Groups are available in our Insights section.
Biologics-based medicines are an extremely promising avenue for therapeutics. Given their size, they are extremely sensitive once they enter the gastrointestinal system. For the launch of Oxford Global’s first Formulation & Drug Delivery Discussion Group, we are bringing together thought-leaders discussing the oral delivery of biologics; with an in-depth discussion pertaining to their permeability and bioavailability and explore which drugs are fit to be delivered orally emphasizing the importance of knowing the therapeutic area to target.
Presentation: Oral Delivery Of Biologics – Quo Vadis?
Speaker: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim
Panel Discussion: Oral Delivery of Biologics – Current Challenges & Opportunities
Moderator: Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim